Maravai LifeSciences Holdings Inc (MRVI)
10.46
+0.62
(+6.30%)
USD |
NASDAQ |
May 10, 16:00
10.46
0.00 (0.00%)
After-Hours: 19:50
Maravai LifeSciences Holdings Revenue (Quarterly): 64.18M for March 31, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 64.18M |
| December 31, 2023 | 74.14M |
| September 30, 2023 | 66.86M |
| June 30, 2023 | 68.91M |
| March 31, 2023 | 79.02M |
| December 31, 2022 | 204.71M |
| September 30, 2022 | 191.26M |
| June 30, 2022 | 242.73M |
| March 31, 2022 | 244.29M |
| Date | Value |
|---|---|
| December 31, 2021 | 228.44M |
| September 30, 2021 | 204.81M |
| June 30, 2021 | 217.78M |
| March 31, 2021 | 148.21M |
| December 31, 2020 | 98.35M |
| September 30, 2020 | 87.86M |
| June 30, 2020 | 46.90M |
| March 31, 2020 | 50.98M |
| December 31, 2019 | 35.96M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
35.96M
Minimum
Dec 2019
244.29M
Maximum
Mar 2022
130.86M
Average
93.11M
Median
Revenue (Quarterly) Benchmarks
| ModivCare Inc | 684.45M |
| Dyadic International Inc | 0.6865M |
| Enveric Biosciences Inc | -- |
| Monopar Therapeutics Inc | -- |
| SeaStar Medical Holding Corp | -- |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -12.08M |
| Total Expenses (Quarterly) | 84.25M |
| EPS Diluted (Quarterly) | -0.09 |
| Enterprise Value | 1.628B |
| Gross Profit Margin (Quarterly) | 40.27% |
| Profit Margin (Quarterly) | -18.82% |
| Earnings Yield | -9.46% |
| Normalized Earnings Yield | -47.68 |